eClinical Solutions Market Size to Reach USD 16.36 BN by 2027

The global eClinical solutions market size is expected to reach over USD 16.36 billion by 2027 and is expanding growth at a CAGR 13.6% during the forecast period 2021 to 2027.

An e-Clinical solution manages clinical technologies and knowledge to assist speed up the clinical development process. E-clinical solutions refer to the usage of electronic solutions and associated processes to support clinical trial processes by automating formerly manual activities. With the growing emphasis on clinical trials in the pharmaceutical and biotechnology industries, the demand for eclinical solutions is increasing at a rapid pace during the forecast period.

Get the sample copy of report@ https://www.precedenceresearch.com/sample/1092

The expanding numbers of clinical trials as well as the growing need for greater data standards and clinical trial outsourcing are propelling the growth of the eclinical solutions market. The rising focus of pharmaceutical and biopharmaceutical companies on novel drug discovery for the treatment of different chronic diseases is a major driver driving eclinical solutions market expansion. Additionally, increased investment in clinical research ensures the acceptance and adoption of e-clinical solutions software is adopted. This will increase demand and accelerate eclinical solutions market growth throughout the forecast period. The eclinical solutions market growth will be augmented by the growing need for global clinical trials and the requirement for quality auditing. As a result, the pharmaceutical and biotechnology industries’ growing expenditure on clinical research and development is propelling the eclinical solutions market forward.

Report Highlights:

• Based on the product, the electronic clinical outcome assessment segment dominated the global eclinical solutions market in 2020 with highest market share. The electronic clinical outcome assessment aids in the preservation of overall quality and is fetching more widely used in the measurement of patient’s
• Based on the delivery mode, the web-hosted segment dominated the global eclinical solutions market in 2020 with highest market share. The segment’s prominence can be due to associated benefits like ease of access, cheaper investment requirements, and usability. As web-hosted goods are highly configurable and providers can customize information display for different user groups.
• Based on the end use, the CROs segment dominated the global eclinical solutions market in 2020 with highest market share. The increased growth of this segment might be attributed to the advantages of outsourcing clinical trials to CROs. The rising service efficiency, cost savings, and a greater focus on key development areas crucial to a company’s success are just a few of the advantages.
• North America is the largest segment for eclinical solutions market in terms of region. The eclinical solutions market is expected to increase due to an increasing target population and the rising prevalence of lifestyle-related diseases such as heart ailments and diabetes. Additionally, the region’s market is being driven by the launch of new products by eclinical solution providers and the surge in government funds.
• Asia-Pacific region is the fastest growing region in the eclinical solutions market. The region’s demand for software solutions is being fueled by unmet medical needs and the increased prevalence of key chronic diseases such as infectious diseases, cancer, and cardiovascular diseases.

Future of eClinical Solutions Market

In the near future, the eclinical solutions market will expand due to rising demand for randomization solutions to compare a new treatment to an existing treatment. Furthermore, phase III clinical trials show and confirm preliminary evidence gathered in previous trials that the medications are safe, effective, and beneficial for the intended indication. To determine the drug’s effectiveness, phase III necessitates a large number of market players. As a result, demand for data management solutions will rise, enhancing the growth of the eclinical solutions industry.

COVID-19 Impact Analysis:

• The COVID-19 pandemic has marked a turning point in the eclinical solutions market. The majority of pharmaceutical and biotechnology businesses have denoted their research and development efforts to assisting in the development of a COVID-19 vaccine.
• In the fight against COVID-19, several market players have spent a large amount of money on analytics, which is creating opportunities for the growth of the eclinical solutions market.

Key Developments in the Marketplace:

• Medidata established collaboration with TriNetX and Datavant in October 2020, with the goal of accelerating the use of real-world data to enhance clinical research. This has improved the firm’s development capacity and helped them boost their market position.
• Signant Health bought VirTrial, a major provider of software for remote site establishment and decentralized clinical trial conduct, in November 2020.
• Clinical Ink, a provider of clinical trial technology, was acquired by GI Partners, a major investment group, in August 2020.
• In January 2021, Parexel International Corporation partnered with Signify Health to provide new solutions to their customers that would allow them to access a more diverse and historically neglected population for their clinical trials.

Segments Covered in the Report

This research study comprises complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers classification of marketplace into impending and niche sectors. Further, this research study calculates market size and its development drift at global, regional, and country from 2016 to 2027. This report contains market breakdown and its revenue estimation by classifying it on the basis of product, development phase, delivery mode, end-use, and region:

By Product

• EDC & CDMS
• eCOA
• Clinical Data Integration Platforms
• CTMS
• Safety Solutions
• RTSM
• Clinical Analytics platforms
• eTMF

By Development Phase

• Phase IV
• Phase III
• Phase II
• Phase I

By Delivery Mode

• Licensed Enterprise
• Web-hosted
• Cloud-based

By End-Use

• CROs
• Hospitals
• Academic Institutes
• Medical Device Manufacturers
• Pharma & Biotech Organizations

By Regional Outlook

• North America
• Europe
• Asia Pacific
• Rest of the World

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1092

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333